Vergoeding 2019-2023 voor ATC-subgroep G04CA : Alfa-blokkers
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| G04CA01 Alfuzosine | 911.850 | 847.730 | 787.350 | 784.390 | 810.810 |
| G04CA02 Tamsulosine (Omnic ®) | 2.018.700 | 2.069.900 | 1.916.200 | 1.947.000 | 1.946.900 |
| G04CA03 Terazosine (Hytrin ®) | 57.170 | 55.434 | 17.393 | 14.410 | 9.494 |
| G04CA04 Silodosine (Silodyx ®) | 934.020 | 911.590 | 858.500 | 913.600 | 913.060 |
| G04CA52 Tamsulosine met dutasteride (Combodart ®) | 9.084.200 | 7.295.100 | 3.223.300 | 2.267.800 | 2.035.400 |
| G04CA53 Tamsulosine met solifenacine (Vesomni ®) | 3.333.500 | 3.545.300 | 3.862.800 | 4.347.000 | 4.654.000 |
| Totaal | 16.339.440 | 14.725.054 | 10.665.543 | 10.274.200 | 10.369.664 |